Seven Grand Managers’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SFCM
Seven Grand Managers's MTRI Position: Q3 2026 in Review
Seven Grand Managers held its Mentari Therapeutics, Inc. Common Stock (MTRI) position steady in Q3 2026 at 2,500 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #153.
Seven Grand Managers first reported a position in MTRI in Q2 2026 and has held it in 2 quarters since. The position peaked at $38.8K in Q2 2026. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.
- Seven Grand Managers held 2,500 shares of Mentari Therapeutics, Inc. Common Stock worth $34K as of Q3 2026.
- Seven Grand Managers left its Mentari Therapeutics, Inc. Common Stock share count unchanged in Q3 2026.
- Mentari Therapeutics, Inc. Common Stock made up ﹤0.01% of Seven Grand Managers's portfolio in Q3 2026, its #153 holding.
- Seven Grand Managers first reported a position in Mentari Therapeutics, Inc. Common Stock in Q2 2026 and has held it in 2 quarters since.
- Seven Grand Managers's Mentari Therapeutics, Inc. Common Stock position peaked at $38.8K in Q2 2026.
- 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.
Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.